Seeding nucleofected hPSCs in 96-well plates using limited dilution

Yogendra Verma, Hanqin Li, Dirk Hockemeyer, Frank Soldner

Published: 2022-09-06 DOI: 10.17504/protocols.io.b4miqu4e

Abstract

This protocol describes a standard procedure for seeding nucleofected human pluripotent stem cells in 96-well plates using limited dilution. This protocol follows nucleofection of hPSCs as described in detail in the collection "Nucleofection (Amaxa) and electroporation (Biorad) of hPSCs;" dx.doi.org/10.17504/protocols.io.b4qnqvve

General notes

  1. Throughout this protocol, the term hPSC is used to collectively refer to both hiPSCs and hESCs. All described procedures have been tested and work equally well for hiPSCs and hESCs.

Steps

1.

For an editing with 10% efficiency, prepare two 96-well MEFs plates with a density at 2 million cells/plate at least 1 day ahead. Do not shake the plate after seeding MEFs. It generates swirls and causes cells to accumulate at the center. If editing efficiency is expected to be low, prepare more 96-well plates.

2.

Calculate the number of cells needed. Cells should be seeded at a density that gives 20-30 colonies/plate. The density depends on cell survival post nucleofection, and varies between cell lines.

Note
For WIBR3 cells, we seed 1,000 cells per plate.

3.

For every seeding density, make and label falcon tubes with 11 ml of hPSC medium + Rock inhibitor. Add the appropriate amount of cell solution to reach your desired cell concentration.

3.1.

hPSC medium

AB
DMEM/F12385 ml
Fetal Bovine Serum (FBS)75 ml
Knockout Serum Replacement25 ml
L-Glutamine (100X)5 ml
Penicillin & Streptomycin (100X)5 ml
MEM Non-Essential Amino Acids (100X)5 ml
2-Mercaptoethanol (10,000X)50 µl
Heat Stable Recombinant Human FGF2 (25ug/ml)*80 µl

*While we prefer Heat Stable Recombinant Human FGF2, we also have used regular FGF2. Final volume: 500ml

L-Glutamine (100X)

AB
L-Glutamine, powder14.6 g
MilliQ H2O500 ml

2-Mercaptoethanol (10,000X)

AB
2-Mercaptoethanol0.78 ml
MilliQ H2O9.22 ml

Heat Stable Recombinant Human FGF2 (25µg/ml)

AB
Heat Stable Recombinant Human FGF2500 µg
0.1% BSA20 ml

Final volume: 20ml

Y-27632 (1,000X)

AB
Y-276325 mg
DMSO1.56 ml

hPSC medium + Rock inhibitor

AB
hPSCs medium500 ml
Y-27632 (1,000X)500 µl

Final volume: 500ml

4.

Take out 96-well MEF plates, carefully label them with their cell seeding number.

5.

Aspirate feeder medium from the plates, then add 100 µl/well using a multichannel pipette and 200 µl filter tips. Use a sterile reagent reservoir for medium.

6.

Additionally, prepare one well of a 6-well plate for each seeding density on your 96-well format. Seed the same number of cells that were seeded to the 96-well plate to this well, e.g. 1,000 cells. These will be analyzed in parallel to track the approximate number of expected colonies/clones from the 96-well plates.

7.

Seed the rest of cells to another well of a 6-well plate. This will become the bulk sample for estimating the editing efficiency. Change medium daily starting from day 3 for this well and prepare crude cell lysis once it reaches a good confluency.

7.1.

Crude lysis buffer (2x)

AB
KCl100mM
MgCl24mM
NP-400.9%
Tween-200.9%
Tris20mM
Proteinase K (add before use)500µg/ml

pH: 8

8.

Change medium for your 96-well plates by using a multi-channel pipet and aspirator every three days. Reduce it to once every two days once the colonies in your plates grow bigger, or during the second week post-nucleofection.

9.

Keep cells in culture for 10-14 days. Proceed with plate duplication if the well in the 6-well plate (originally seeded with 1,000 cells) shows 20-50 colonies.

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询